
Last modified: January 10, 2010
Offices[edit]
People[edit]
Web Presences[edit]
- Biotech & Life Sciences
- Health IT
Industries[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
|
|
Description[edit]
Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology.
The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences.
STI was formed in 2006 in San Diego, California. In September 2009, STI and Quikbyte Software, Inc., a publicly traded shell company, merged and adopted STI’s name.
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| Sorrento Therapeutics Job Trends | Sorrento Therapeutics Jobs |
Loading web traffic statistics. Please wait...
- Biotech Showcase 2010 - Presenting Companies (3 subscribers)
This Company is Being Watched in
Recent Updates |
|---|
| Sorrento Therapeutics has been added to the Ecosystem. |






